PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmacy, Chiba University Hospital, Japan.\', \'Division of Pharmacy, Chiba University Hospital, Japan; Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Japan. Electronic address: takaakis@chiba-u.jp.\', \'Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Japan.\', \'Division of Infection Control, Chiba University Hospital, Japan.\', \'Division of Pharmacy, Chiba University Hospital, Japan; Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(20)30456-610.1016/j.jiac.2020.12.021
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33402301
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all